Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes.
about
Interleukin-10: new perspectives on an old cytokineActivation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?Regulation of interleukin-10 receptor ubiquitination and stability by beta-TrCP-containing ubiquitin E3 ligaseVirus-encoded homologs of cellular interleukin-10 and their control of host immune function.TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients.Daily Moderate Exercise Is Beneficial and Social Stress Is Detrimental to Disease Pathology in Murine Lupus NephritisFailure of gamma interferon but not interleukin-10 expression in response to human papillomavirus type 11 E6 protein in respiratory papillomatosis.Endogenous interleukin-10 is required for prevention of a hyperinflammatory intracerebral immune response in Listeria monocytogenes meningoencephalitis.Current status of interleukin-10 and regulatory T-cells in cancerT-cell-directed cancer vaccines: mechanisms of immune escape and immune tolerance.Cytokine therapy in dermatology.Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus-induced encephalitis.Interleukin-10 and pathogenesis of murine ocular toxoplasmosis.Cytokine and anticytokine therapy in dermatology.IL-10-induced gp130 expression in mouse mast cells permits IL-6 trans-signaling.The molecular basis of IL-10 function: from receptor structure to the onset of signaling.IL-10 signaling in CD4+ T cells is critical for the pathogenesis of collagen-induced arthritis.Contribution of Reduced Interleukin-10 Levels to the Pathogenesis of Osteomyelitis in Children with Sickle Cell Disease.Variation in inflammatory/regulatory cytokines in secondary, tertiary, and quaternary challenges with dengue virus.Interleukin-10 and the immune response against cancer: a counterpoint.The role of IL-10 in regulating immunity to persistent viral infectionsCirculating interleukin-10 levels and human papilloma virus and Epstein-Barr virus-associated cancers: evidence from a Mendelian randomization meta-analysis based on 11,170 subjects.Expanding roles for CD4 T cells and their subpopulations in tumor immunity and therapy.Advances in dendritic-cell-based therapeutic vaccines for cervical cancer.Effect of Th1/Th2 cytokine administration on proinflammatory SKOV-3 cell activation.Cytokine networks in glioma.The dual nature of interleukin-10 in pemphigus vulgaris.Human Leukocyte Antigen Class I and Class II Polymorphisms and Serum Cytokine Profiles in Cervical Cancer.Immunotherapy and targeted therapy for cervical cancer: an update.Gonadotrophin stimulation in IVF alters the immune cell profile in follicular fluid and the cytokine concentrations in follicular fluid and serum.Lymphocytes and macrophages in adipose tissue in obesity: markers or makers of subclinical inflammation?Autocrine Complement Inhibits IL10-Dependent T-cell-Mediated Antitumor Immunity to Promote Tumor Progression.Early human pregnancy serum cytokine levels predict autoimmunity in offspring.Immunomodulatory activities of a new pentapeptide (Bursopentin) from the chicken bursa of Fabricius.Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes.Use and specificity of breast cancer antigen/milk protein BA46 for generating anti-self-cytotoxic T lymphocytes by recombinant adeno-associated virus-based gene loading of dendritic cells.Interleukin 10 promotes immune response by increasing the survival of activated CD8+ T cells in human papillomavirus 16-infected cervical cancer.A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells.Pro-Inflammatory Signaling by IL-10 and IL-22: Bad Habit Stirred Up by Interferons?Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis.
P2860
Q24653771-0A6692C9-2AA9-4362-A2BE-22DC369F7700Q27478400-F56D1C4D-A13B-4A78-AD1D-5E834A2EB435Q28477869-80734B6E-EC37-4000-BCF8-F85C4EF586F7Q30436621-10501C4B-796C-4172-BAFD-F44BC185735BQ30841163-185F792B-EDCF-4ADC-B00D-2A436E7DE98DQ33603442-1824FF0F-07B8-4640-9485-398EDEF2C452Q33712058-09BC1EBE-C2A4-4B80-A073-CAA84502E65AQ34008352-D5648D94-56F7-4955-B106-37F68C1A1228Q34374026-7FE24EA9-ED74-4BD2-B1AB-A458AE3C886EQ34452013-3F0A6E31-10AF-4BE2-9FB8-5CC74D861D53Q34626999-D2C9AEF7-ECD0-4EB6-B981-B86543A6B1D1Q34713380-A3BC709F-B02A-4440-9CE9-82A561F0F7B4Q34946268-F1F1E918-C970-4F0C-8249-2E59F1B95629Q35184711-39BF2F0C-5538-4A61-B2A4-01882B9602ADQ35787352-013111C4-89F2-4FE4-A6A2-C545475CF813Q35810601-A9D77F2D-0CBA-4FD3-ADA3-C94F773B43BFQ35907840-FC76E918-00CE-4EF3-A8A6-3C7FDACFD329Q35998763-820FA1C5-5476-47F8-BDE7-2DB8FB0580F0Q36213311-FD258DF0-3533-451A-B8C3-1A2437A87CBCQ36276594-752AA933-94BD-4D13-8EAC-E78221464880Q36380567-E83CE2BA-58AD-4DEB-8DE6-76F7D83A59AAQ36677481-99458F00-B3DD-45FF-BFD7-15B6801804ADQ36715205-0944BEDF-DB8E-4FE2-BEF5-5AA070376221Q36974722-BA86895E-B1A5-4BF1-B4CE-B881F451B04BQ37412635-A1E3C062-51ED-4FBD-9E9A-681F617EFD44Q37886819-C315640C-C2B1-4289-8C21-D62E6C21F1F2Q38281273-E622CC49-CDD9-4D58-A214-3448BE164A33Q38600163-0C4C434B-8146-4542-A2B0-6974F54F4F42Q38633525-A2A8916D-D22B-41A2-9E44-C298E7F051F5Q38959973-97439D00-7020-4248-B7B3-C151A537A622Q38985223-615E74D5-C377-490C-92D7-C53E2F4BC94CQ39686133-254EF658-7EA7-4021-9100-52FBC6FCA557Q39784835-C27CCAAA-D047-4A35-9309-484A04DE7B8AQ39859752-582EDCC8-D122-4F5D-8627-692DB2B853F3Q39997530-3B6989DF-FE04-4A5D-985A-9921ADD86A7CQ40487777-697BFC75-5593-4632-97CC-92781BAD6D7AQ40509670-F410A4D9-DDEB-4D75-9823-E69AB6C09E79Q40605843-AA7200FE-C984-4B93-9EC6-57DD60F7554EQ41999154-8A78E870-24B1-499D-9190-44789136450BQ42447593-D2AAF6D4-EA2C-48E8-B2D8-F20080E596E4
P2860
Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Interleukin-10 increases Th1 c ...... D8(+) cytotoxic T lymphocytes.
@ast
Interleukin-10 increases Th1 c ...... D8(+) cytotoxic T lymphocytes.
@en
type
label
Interleukin-10 increases Th1 c ...... D8(+) cytotoxic T lymphocytes.
@ast
Interleukin-10 increases Th1 c ...... D8(+) cytotoxic T lymphocytes.
@en
prefLabel
Interleukin-10 increases Th1 c ...... D8(+) cytotoxic T lymphocytes.
@ast
Interleukin-10 increases Th1 c ...... D8(+) cytotoxic T lymphocytes.
@en
P2093
P2860
P1433
P1476
Interleukin-10 increases Th1 c ...... D8(+) cytotoxic T lymphocytes.
@en
P2093
A D Santin
G P Parham
M J Cannon
P L Hermonat
S Pecorelli
P2860
P304
P356
10.1128/JVI.74.10.4729-4737.2000
P577
2000-05-01T00:00:00Z